Loading…
Ganga Pharmaceuticals (BSE 539680)₹12.50+4.17%Pharmaceuticals
At the end of the Mar 2026 quarter, Ganga Pharmaceuticals' shareholders were: promoters 50.87%, public 49.13%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 364 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Promoters | 66.67% | 55.98% | 55.98% | 55.98% | 50.87% | 50.87% |
| Public | 33.33% | 44.02% | 44.02% | 44.02% | 49.13% | 49.13% |
| Promoter shares pledged | — | — | — | — | — | 0.00% |
| Number of shareholders | 358 | 362 | 364 | 367 | 365 | 364 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Sharma Bharat B | Promoter | 24.68% | — |
| Srijna Sharma | Promoter | 7.47% | — |
| Bhavesh Dhirajlal Tanna | Public | 6.65% | — |
| Lenus Finvest Private Limited | Public | 6.37% | — |
| Plutus Capital Management Llp | Public | 6.37% | — |
| Anagh Bharat Sharma | Promoter | 6.08% | — |
| Brijmohan Sharma Huf | Promoter | 5.95% | — |
| Prakash Dhirajlal Tanna | Public | 5.51% | — |
| Bharat Brijmohan Sharma Huf Sharma | Promoter | 3.22% | — |
| Niranjan Kumar Goel | Public | 2.43% | — |
| Usha Shukla | Promoter | 1.60% | — |
| Amit Shukla | Promoter | 1.28% | — |
| Sanjay Dhansukhlal Shah | Public | 1.23% | — |
| Akshay Amarnath Sharma | Public | 1.21% | — |
| Ankita Amit Shukla | Promoter | 0.68% | — |
Promoters held 50.87% of Ganga Pharmaceuticals at the end of the Mar 2026 quarter, down 5.11 percentage points from 55.98% a year earlier.
No. The Mar 2026 filing shows no pledged promoter shares.
Ganga Pharmaceuticals had 364 shareholders at the end of the Mar 2026 quarter, against 362 a year earlier.
Bhavesh Dhirajlal Tanna (Public) held 6.65% at the end of the Mar 2026 quarter, the largest named holding outside the promoter group.